Cost-effectiveness of omalizumab in real world uncontrolled allergic asthma patients A. Arrobas, M.P. Barbosa, S. Rabiais, B. Vandewalle, J. Félix

Mepolizumab for severe eosinophilic asthma – A one-year real life Portuguese study R Brás, M Paulino, C Varandas, C Coutinho, MI Silva, R Limão, C Costa, E Alonso, E Pedro, A Mendes

Are patients with autoimmune disorders eligible for immunotherapy? D. Madama, A. Pego